|
CB-TH
|
ARG-TRP-LYS-ILE-PHE-LYS-LYS-ILE-GLU-LYS-MET-GLY-GLY-SER-TYR-CYS-ASN-ARG-ARG-THR-GLY-LYS-CYS-GLN-ARG-MET
|
|
|
DAP10 Signaling Fragment
|
PRO-ALA-GLN-GLU-ASP-GLY-LYS-VAL-TYR-ILE-ASN-MET-PRO-GLY-ARG-GLY
|
|
|
Bid BH3-r8
|
D-ARG-D-ARG-D-ARG-D-ARG-D-ARG-D-ARG-D-ARG-D-ARG-GLY-GLU-ASP-ILE-ILE-ARG-ASN-ILE-ALA-ARG- HIS-LEU-ALA-GLN-VAL-GLY-ASP-SER-MET-ASP-ARG
|
|
|
Tachykinin (111-129) Beta-Prepro (Human)
|
ALA-LEU-ASN-SER-VAL-ALA-TYR-GLU-ARG-SER-ALA-MET-GLN-ASN-TYR-GLU-ARG-ARG-ARG
|
|
|
BTK derived peptide
|
LYS-LYS-VAL-VAL-ALA-LEU-TYR-ASP-TYR-MET-PRO-MET-ASN-NH2
|
|
|
D-D-D-D-D-D
|
ASP-ASP-ASP-ASP-ASP-ASP
|
|
|
Glu3,4,7,10,14]-Conantokin G
|
(GLU3·4·7·10·14)-CONANTOKIN G
|
|
|
A-G-D-V
|
ALA-GLY-ASP-VAL
|
|
|
Ile12,Val15] MUC5AC Analog 3
|
GLY-THR-THR-PRO-SER-PRO-VAL-PRO-THR-THR-SER-ILE-THR-SER-VAL-PRO
|
|
|
Bone Matrix Proteins
|
GLU-ILE-ASN-LEU-SER-HIS-ASN-LYS
|
|
|
Dok-4 (130-145)
|
GLY-VAL-GLN-CYS-GLU-GLN-THR-ASP-ARG-PHE-ASN-VAL-PHE-LEU-LEU-PRO
|
|
|
Dok-4 (263-275)
|
LEU-PRO-ARG-SER-ALA-TYR-TRP-HIS-HIS-ILE-THR-GLY-SER
|
|
|
Antiestrogen
|
CYS-ASN-VAL-VAL-PRO-LEU-TYR(PO3H2)-ASP-LEU-LEU-LEU-GLU
|
|
|
SCPA
|
ALA-ARG-PRO-GLY-TYR-LEU-ALA-PHE-PRO-ARG-MET-NH2
|
|
|
β-Ala70]-C3a (70-77)
|
H-Β-ALA-SER-HIS-LEU-GLY-LEU-ALA-ARG-OH
|
|
|
IRL-1720
|
AC-ASP-LYS-GLU-ALA-VAL-TYR-PHE-ALA-HIS-LEU-ASP-ILE-ILE-TRP
|
|
|
Ep-CAM (263-271)
|
GLY-LEU-LYS-ALA-GLY-VAL-ILE-ALA-VAL
|
|
|
A-A-A-Y-G-G-F-L
|
ALA-ALA-ALA-TYR-GLY-GLY-PHE-LEU
|
|
|
Delta (Phospho) Sleep Inducing Peptide
|
TRP-ALA-GLY-GLY-ASP-ALA-SER(PO3H2)-GLY-GLU
|
|
|
Achatin-1
|
GLY-D-PHE-ALA-ASP
|
|
|
D-Ser14]-Humanin (HN)
|
MET-ALA-PRO-ARG-GLY-PHE-SER-CYS-LEU-LEU-LEU-LEU-THR-D-SER-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA
|
|
|
Abltide
|
LYS-LYS-GLY-GLU-ALA-ILE-TYR-ALA-ALA-PRO-PHE-ALA-NH2
|
|
|
C3a (72-77) (human)
|
HIS-LEU-GLY-LEU-ALA-ARG
|
|
|
A-K-R-R-R-L-S-S-L-R-A
|
ALA-LYS-ARG-ARG-ARG-LEU-SER-SER-LEU-ARG-ALA
|
|
|
Acyl Carrier Protein (65-74) (acid)
|
VAL-GLN-ALA-ALA-ILE-ASP-TYR-ILE-ASN-GLY
|
|
|
5A/5B Peptide (1)
|
GLU-ASP-VAL-VAL-ABU-CYS-SER-MET-SER-TYR
|
|
|
Conantokin T, Marine snail, Conus tullpa
|
GLY-GLU-GLA-GLA-TYR-GLN-LYS-MET-LEU-GLA-ASN-LEU-ARG-GLA-ALA-GLU-VAL-LYS-LYS-ASN-ALA-NH2
|
|
|
Bid BH3
|
ARG-ASN-ILE-ALA-ARG-HIS-LEU-ALA-GLN-VAL-GLY-ASP-SER-MET-ASP-ARG
|
|
|
Cathepsin G (77-83)
|
HIS-PRO-GLN-TYR-ASN-GLN-ARG
|
|
|
ADP-Ribosylation Factor 6, ARF6 (2-13)
|
GLY-LYS-VAL-LEU-SER-LYS-ILE-PHE-GLY-ASN-LYS-GLU
|
|
|
BDC 2.5(A)
|
GLY-LYS-LYS-VAL-ALA-ALA-PRO-ALA-TRP-ALA-ARG-MET-GLY
|
|
|
Bid BH3-r9
|
ARG-ARG-ARG-ARG-ARG-ARG-ARG-ARG-ARG-GLY-GLU-ASP-ILE-ILE-ARG-ASN-ILE-ALA-ARG-HIS-LEU-ALA-GLN-VAL-GLY-ASP-SER-MET-ASP-ARG
|
|
|
Biotin-Intermedin (human)
|
BIOTIN-THR-GLN-ALA-GLN-LEU-LEU-ARG-VAL-GLY-CYS-VAL-LEU-GLY-THR-CYS-GLN-VAL-GLN-ASN-LEU-SER-HIS-ARG-LEU-TRP-GLN-LEU-MET-GLY-PRO-ALA-GLY-ARG-GLN-ASP-SER-ALA-PRO-VAL-ASP-PRO-SER-SER-PRO-HIS-SER-TYR-NH2
|
|
|
Biotin-LC-Kemptide
|
BIOTIN-LC-LEU-ARG-ARG-ALA-SER-LEU-GLY
|
|
|
Ala8]-Humanin, [Ala8]-HN, Shna
|
MET-ALA-PRO-ARG-GLY-PHE-SER-ALA-LEU-LEU-LEU-LEU-THR-SER-GLU-ILE-ASP-LEU-PRO-VAL-LYS-ARG-ARG-ALA
|
|
|
GAD65 (206-220)
|
THR-TYR-GLU-ILE-ALA-PRO-VAL-PHE-VAL-LEU-LEU-GLU-TYR-VAL-THR
|
|
|
Neuron Specific Peptide
|
ASP-VAL-SER-ASP-GLY-SER-ALA-GLU-ARG-ARG-PRO-TYR-THR-ARG-MET-GLY-SER-GLY-GLY-LEU-LYS-LEU-HIS-CYS-VAL-HIS-PRO-ALA-ASN-CYS-PRO-GLY-GLY-LEU-MET-VAL-THR
|
|
|
Erythromycin resistance peptide
|
MET-ARG-LEU-PHE-VAL
|
|
|
Acyl Carrier Protein (65-74) (amide)
|
VAL-GLN-ALA-ALA-ILE-ASP-TYR-ILE-ASN-GLY-NH2
|
|
|
4A/4B, Peptide (1)
|
ASP-GLU-MET-GLU-GLU-CYS-SER-GLN-HIS-LEU-PRO-TYR-ILE
|
|
|
Anti-Flt1 Peptide
|
GLY-ASN-GLN-TRP-PHE-ILE
|
|
|
Biotin-Kemptide
|
BIOTIN-LEU-ARG-ARG-ALA-SER-LEU-GLY
|
|
|
Cripto-1, CR-1
|
CYS-PRO-PRO-SER-PHE-TYR-GLY-ARG-ASN-CYS-GLU-HIS-ASP-VAL-ARG-LYS-GLU
|
|
|
Catch-Relaxing Peptide (CARP)
|
ALA-MET-PRO-MET-LEU-ARG-LEU-NH2
|
|
|
Bak-BH3
|
GLY-GLN-VAL-GLY-ARG-GLN-LEU-ALA-ILE-ILE-GLY-ASP-ASP-ILE-ASN-ARG
|
|
|
APLILSR]pPSA
|
ALA-PRO-LEU-ILE-LEU-SER-ARG-ILE-VAL-GLY-GLY-TRP-GLU-CYS-GLU-LYS
|
|
|
SMAP 29, Sheep Myeloid Antimicrobial Peptide 29
|
ARG-GLY-LEU-ARG-ARG-LEU-GLY-ARG-LYS-ILE-ALA-HIS-GLY-VAL-LYS-LYS-TYR-GLY-PRO-THR-VAL-LEU-ARG-ILE-ILE-ARG-ILE-ALA-GLY
|
|
|
Bax-BH3
|
LYS-LYS-LEU-SER-GLU-CYS-LEU-LYS-ARG-ILE-GLY-ASP-GLU-LEU-ASP-SER
|
|
|
E75, Her-2/neu (369-377)
|
LYS-ILE-PHE-GLY-SER-LEU-ALA-PHE-LEU
|
|
|
Dermorphin Analog
|
TYR-D-ARG-PHE-SAR-TYR-PRO-SER-NH2
|
|
|
2B-(pS)
|
BIOTIN-ARG-ARG-ALA-ALA-GLU-GLU-LEU-ASP-SER-ARG-ALA-GLY-PSER-PRO-GLN-LEU
|
|
|
Bid BH3 Peptide
|
GLU-ASP-ILE-ILE-ARG-ASN-ILE-ALA-ARG-HIS-LEU-ALA-GLN-VAL-GLY-ASP-SER-MET-ASP-ARG
|
|
|
Biotin-Intermedin (rat)
|
BIOTIN-PRO-HIS-ALA-GLN-LEU-LEU-ARG-VAL-GLY-CYS-VAL-LEU-GLY-THR-CYS-GLN-VAL-GLN-ASN-LEU-SER-HIS-ARG-LEU-TRP-GLN-LEU-VAL-ARG-PRO-SER-GLY-ARG-ARG-ASP-SER-ALA-PRO-VAL-ASP-PRO-SER-SER-PRO-HIS-SER-TYR-NH2
|
|
|
Biotin-LC-Neurogranin (28-43)
|
BIOTIN-LC-ALA-ALA-LYS-ILE-GLN-ALA-SER-PHE-ARG-GLY-HIS-MET-ALA-ARG-LYS-LYS
|
|
|
234 CM
|
LYS-TYR-ILE-CYS-ASN-SER-SER-CYS-MET
|
|
|
CK1tide
|
HIS-ALA-ALA-ILE-GLY-ASP-ASP-ASP-ASP-ALA-TYR-SER-ILE-THR-SER-NH2
|
|
|
Locustachykinin II
|
ALA-PRO-LEU-SER-GLY-PHE-TYR-GLY-VAL-ARG-NH2
|
|
|
PSMA-617 linker, Vipivotide tetraxetan Linker, (10S, 14S)- 1- (4-(aminomethyl)cyclohexyl)-3-(naphthalen-2-ylmethyl)- 1,4, 12-trioxo- 2,5, 11, 13-tetraazahexadecane- 10, 14, 16-tricarboxylic acid
|
Vipivotide tetraxetan Linker
|
1703768-74-4
|
|
Ac-5A/5B Peptide
|
AC-GLU-ASP-VAL-VAL-CYS-CYS-SER-MET-SER-TYR-NH2
|
|
|
BAGE (2-10)
|
ALA-ALA-ARG-ALA-VAL-PHE-LEU-ALA-LEU
|
|
|
Nle13]-Motillin
|
PHE-VAL-PRO-ILE-PHE-THR-TYR-GLY-GLU-LEU-GLN-ARG-NLE-GLN-GLU-LYS-GLU-ARG-ASN-LYS-GLY-GLN
|
|
|
Alternate Syntide
|
PRO-LEU-SER-ARG-THR-LEU-SER-VAL-SER-SER-LEU-PRO-GLY-LEU- NH2
|
|
|
CDPKS,Syntide analog
|
PRO-LEU-ARG-ARG-THR-LEU-SER-VAL-ALA-ALA
|
|
|
FDC-SP (61-85), human
|
PHE-PRO-TRP-PHE-ARG-ARG-ASN-PHE-PRO-ILE-PRO-ILE-PRO-GLU-SER-ALA-PRO-THR-THR-PRO-LEU-PRO-SER-GLU-LYS
|
|
|
2B-(A)
|
BIOTIN-ARG-ARG-ALA-ALA-GLU-GLU-LEU-ASP-SER-ARG-ALA-GLY-ALA-PRO-GLN-LEU
|
|
|
Kassinin
|
ASP-VAL-PRO-LYS-SER-ASP-GLN-PHE-VAL-GLY-LEU-MET-NH2
|
|
|
BZ-ILE-GLU-GLY-ARG-PNA
|
BZ-ILE-GLU-GLY-ARG-PNA
|
59068-47-2
|
|
Ac-P-G-A
|
AC-PRO-GLY-ALA
|
|
|
Doc-6 (130-145)
|
GLY-VAL-GLN-ARG-GLU-GLN-ASN-GLU-ARG-PHE-ASN-VAL-TYR-LEU-MET-PRO
|
|
|
EMP-1 (Epithelial Membrane Protein)
|
GLY-GLY-THR-TYR-SER-CYS-HIS-PHE-GLY-PRO-LEU-THR-TRP-VAL-CYS-LYS-PRO-GLN-GLY-GLY
|
|
|
Bax-BH3L63A
|
LYS-LYS-LEU-SER-GLU-CYS-ALA-LYS-ARG-ILE-GLY-ASP-GLU-LEU-ASP-SER
|
|
|
Dok-5 (263-275)
|
LEU-PRO-ARG-SER-ALA-TYR-TRP-GLN-HIS-ILE-THR-ARG-GLN
|
|
|
360 MMP FRET Substrate III
|
荧光底物肽MMP-2
|
135662-07-6
|
|
Pressinoic Acid
|
CYS-TYR-PHE-GLN-ASN-CYS(DISULFIDE BRIDGE CYS1-CYS6)
|
|
|
BAD (103-126),human
|
ASN-LEU-TRP-ALA-ALA-GLN-ARG-TYR-GLY-ARG-GLU-LEU-ARG-ARG-MET-SER-ASP-GLU-PHE-VAL-ASP-SER-PHE-LYS
|
|
|
Experimental Autoimmune Encephalomyelitis Complementary Peptide
|
VAL-PHE-ILE-LEU-GLY-PRO-LEU-ARG-LEU-LEU-GLY
|
|
|
GRP (14-27) (human, porcine, canine)
|
ALA-PRO-VAL-SER-VAL-GLY-GLY-GLY-THR-VAL-LEU-ALA-LYS-MET-TYR-PRO-ARG-GLY-ASN-HIS-TRP-ALA-VAL-GLY-HIS-LEU-MET-NH2: APVSVGGGTVLAKMYPRGNHWAVGHLM-NH2
|
|
|
234 CW
|
LYS-TYR-MET-CYS-ASN-SER-SER-CYS-MET
|
|
|
ADR1-derived peptide
|
LEU-LYS-LYS-LEU-THR-ARG-ARG-ALA-SER-PHE-SER-GLY-GLN
|
|
|
CLIP(85-99)
|
LYS-PRO-VAL-SER-GLN-MET-ARG-MET-ALA-THR-PRO-LEU-LEU-MET-ARG
|
|
|
Dok-6 (263-275)
|
LEU-PRO-ARG-SER-ALA-TYR-TRP-HIS-HIS-ILE-THR-ARG-GLN
|
|
|
F1 Peptide,lobster
|
THR-ASN-ARG-ASN-PHE-LEU-ARG-PHE-NH2
|
|
|
R-G-Y-S-L-G
|
ARG-GLY-TYR-SER-LEU-GLY: RGYSLG
|
|
|
4A/4B, 5A/5B Peptide
|
AC-ASP-GLU-MET-GLU-GLU-CYS-SER-MET-SER-TYR-NH2
|
|
|
2B-(S)
|
BIOTIN-ARG-ARG-ALA-ALA-GLU-GLU-LEU-ASP-SER-ARG-ALA-GLY-SER-PRO-GLN-LEU
|
|
|
4B/5A Peptide
|
GLU-CYS-THR-THR-PRO-CYS-SER-GLY-SER-TRP-LEU-ARG-ASP
|
|
|
H-ILE-VAL-OH
|
异亮氨酰-缬氨酸
|
41017-96-3
|
|
Brevinin-1
|
BREVININ-1
|
|
|
ACTH（5-10）
|
ACTH (5-10)
|
|
|
FDC-SP (30-85), human
|
SER-ILE-SER-ASP-SER-ASP-GLU-LEU-ALA-SER-GLY-PHE-PHE-VAL-PHE-PRO-TYR-PRO-TYR-PRO-PHE-ARG-PRO-LEU-PRO-PRO-ILE-PRO-PHE-PRO-ARG-PHE-PRO-TRP-PHE-ARG-ARG-ASN-PHE-PRO-ILE-PRO-ILE-PRO-GLU-SER-ALA-PRO-THR-THR-PRO-LEU-PRO-SER-GLU-LYS
|
|
|
Adipophilin
|
SER-VAL-ALA-SER-THR-ILE-THR-GLY-VAL
|
|
|
α-Bag Cell Peptide (1-7)
|
ALA-PRO-ARG-LEU-ARG-PHE-TYR
|
|
|
gp38
|
ARG-VAL-THR-ALA-ILE-GLU-LYS-TYR-LEU-GLN-ASP-GLN-ALA- ARG-LEU-ASN-SER-TRP-GLY-CYS-ALA-PHE-ARG-GLN-VAL-CYS(DISULFIDE BRIDGE:CYS20-CYS26)
|
|
|
pSer5]-Kemptide, Biotinylated
|
BIOTIN-LEU-ARG-ARG-ALA-SER(PO3H2)-LEU-GLY
|
|
|
Endonuclease Antigenic Site
|
GLU-THR-GLY-GLN-GLU-THR-ALA-TYR-PHE-LEU-LEU-LYS-LEU-ALA-GLY-ARG-TRP-PRO-VAL-LYS
|
|
|
BAD (103-127), human
|
ASN-LEU-TRP-ALA-ALA-GLN-ARG-TYR-GLY-ARG-GLU-LEU-ARG-ARG-MET-SER-ASP-GLU-PHE-VAL-ASP-SER-PHE-LYS-LYS
|
|
|
Nle253]-HSV-1 UL 26 Open Reading Frame (238-257)
|
(NLE253)-HSV-1 UL 26 OPEN READING FRAME (238-257)
|
|
|
CDR-H3/C2
|
CYS-ASP-LEU-ILE-TYR-TYR-ASP-TYR-GLU-GLU-ASP-TYR-TYR-PHE-ASP-CYS (DISULFIDE BRIDGE: CYS1-CYS16)
|
|
|
ERKtide
|
ALA-THR-GLY-PRO-LEU-SER-PRO-GLY-PRO-PHE-GLY-ARG-ARG
|
|
|
ADP-Ribosylation Factor 1, ARF1 (2-17)
|
GLY-ASN-ILE-PHE-ALA-ASN-LEU-PHE-LYS-GLY-LEU-PHE-GLY-LYS-LYS-GLU
|
|